13,14-Dihydro-15-substituted-.omega.-pentanorprostaglandins
US3974213A · kind A · utility
15Cited by
2References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 3, 1974 |
| Grant date | Aug 10, 1976 |
| Priority date | — |
| Expiry date | Jul 3, 1994 |
Classification
- Technology area (CPC B)Performing Operations; Transporting
- CPC primaryB63B2211/02
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The 15 aryl substituted-.omega.-pentanorprostaglandins and various intermediates employed in their preparation. The novel prostaglandins of this invention have been found to have activity profiles comparable to the parent prostaglandins, but exhibit a greater tissue specificity of action.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.